title: Even though T-cell-directed trials have been of limited success, is there reason for optimism?
authors.affiliation: Department of Rheumatology, Guy's Hospital, King's College London School of Medicine at Guy's, King's College and St Thomas' Hospitals, UK. gabriel.panayi@kcl.ac.uk
authors.forename: Gabriel S
authors.initials: GS
authors.lastname: Panayi
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015703:Antigens, CD / Q000502:physiology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D013601:T-Lymphocytes / Q000187:drug effects / Q000502:physiology*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD